TEMPEST THERAPEUTICS INC (TPST)
US87978U1088 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 32.33M | 39.23M | 31.20M | 51.80M | 38.20M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | 300.00K | |||
| Other Current Assets | 1.17M | 1.13M | 1.70M | 17.20M | 2.40M | |||
| Total Current Assets | 33.50M | 40.36M | 33.00M | 69.00M | 40.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.43M | 10.79M | 12.70M | 4.20M | 2.20M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 448.00K | 448.00K | 400.00K | 100.00K | 400.00K | |||
| Total Non-Current Assets | 10.88M | 11.24M | 13.10M | 4.20M | 2.50M | |||
| TOTAL ASSETS | 44.38M | 51.60M | 46.10M | 73.20M | 43.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 6.46M | 4.29M | N/A | N/A | 200.00K | |||
| Accrued Expenses | 3.18M | 4.28M | 5.70M | 4.00M | 6.30M | |||
| Accounts Payable | 1.05M | 845.00K | 1.10M | 1.00M | 1.50M | |||
| Other Current Liabilities | N/A | 0.00 | 500.00K | 15.00M | N/A | |||
| Total Current Liabilities | 10.69M | 9.41M | 7.30M | 20.00M | 8.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 4.14M | 6.26M | 10.40M | 15.10M | 100.00K | |||
| Other Non-Current Liabilities | 8.91M | 9.16M | 10.30M | 2.00M | 1.60M | |||
| Total Non-Current Liabilities | 13.05M | 15.42M | 20.70M | 17.10M | 2.40M | |||
| TOTAL LIABILITIES | 23.75M | 24.84M | 28.00M | 37.10M | 10.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -173.17M | -165.26M | -135.80M | -100.10M | -245.10M | |||
| Additional Paid In Capital | 193.78M | 192.01M | 153.90M | 136.20M | 277.60M | |||
| Minority Interest | N/A | N/A | N/A | N/A | 700.00K | |||
| Common Shares | 22.00K | 22.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 500.00K | |||
| Shares Outstanding | 22.22M | 22.05M | 10.50M | 6.90M | 1.30M | |||
| Tangible Book Value per Share | 0.93 | 1.21 | 1.72 | 5.23 | 25.46 | |||
| Total Shareholders' Equity | 20.63M | 26.77M | 18.10M | 36.10M | 33.10M | |||
| TOTAL LIABILITIES AND EQUITY | 44.38M | 51.60M | 46.10M | 73.20M | 43.40M | |||
| Statistics | ||||||||
| Debt/Equity | 0.20 | 0.23 | 0.57 | 0.42 | 0.00 | |||
| Current Ratio | 3.13 | 4.29 | 4.52 | 3.45 | 5.11 | |||
| Return On Assets (ROA) | -67.06% | -57.15% | -77.46% | -38.66% | -83.89% | |||
| Return On Equity (ROE) | -144.25% | -110.17% | -197.29% | -78.39% | -110.00% | |||
All data in USD